DOTA-LIS-02 emerged as the most promising candidate among the different lisinopril-based conjugates, which could be useful for imaging physiological levels of ACE in cardiovascular disease and Covid-19 after labeling with PET radiometals such as gallium-68 or scandium-44. Here, ACE is linked to cardiovascular disorder.